Abstract:BackgroundAlzheimer's disease (AD) is the most common form of age-related neurodegenerative disease. Unfortunately, due to the complexity of pathological types and clinical heterogeneity of AD, there is a lack of satisfactory treatment for AD. Previous studies have shown that microRNAs and transcription factors can modulate genes associated with AD, but the underlying pathophysiology remains unclear. MethodsThe datasets GSE1297 and GSE5281 were downloaded from the gene expression omnibus (GEO) database and analyzed to obtain the differentially expressed genes (DEGs) through the "R" language "limma" package. The GSE1297 dataset was analyzed by weighted correlation network analysis (WGCNA), and the key gene modules were selected. Next, gene ontology (GO) and Kyoto encyclopedia of genes and genomes (KEGG) pathway enrichment analysis for the key gene modules were performed. Then, the protein-protein interaction (PPI) network was constructed and the hub genes were identified using the STRING database and Cytoscape software. Finally, for the GSE150693 dataset, the "R" package "survivation" was used to integrate the data of survival time, AD transformation status and 35 characteristics, and the key microRNAs (miRNAs) were selected by Cox method. We also performed regression analysis using least absolute shrinkage and selection operator (Lasso)-Cox to construct and validate prognostic features associated with the four key genes using different databases. We also tried to find drugs targeting key genes through DrugBank database. ResultsGO and KEGG enrichment analysis showed that DEGs were mainly enriched in pathways regulating chemical synaptic transmission, glutamatergic synapses and Huntington's disease. In addition, 10 hub genes were selected from the PPI network by using the algorithm Between Centrality. Then, four core genes (TBP, CDK7, GRM5, and GRIA1) were selected by correlation with clinical information, and the established model had very good prognosis in different databases. Finally, hsa-miR-425-5p and hsa-miR-186-5p were determined by COX regression, AD transformation status and aberrant miRNAs. ConclusionIn conclusion, we tried to construct a network in which miRNAs and transcription factors jointly regulate pathogenic genes, and described the process that abnormal miRNAs and abnormal transcription factors TBP and CDK7 jointly regulate the transcription of AD central genes GRM5 and GRIA1. The insights gained from this study offer the potential AD biomarkers, which may be of assistance to the diagnose and therapy of AD.

Identifying Tmem59 Related Gene Regulatory Network of Mouse Neural Stem Cell from A Compendium of Expression Profiles

Effects Of Neural Stem Cells On Synaptic Proteins And Memory In A Mouse Model Of Alzheimer'S Disease

[Effects of Transplanted Neural Stem Cells on Synaptogenesis in APP/PS1 Mice].

Effect of Neural Stem Cells Transplantation on Protein Expressions of Doublecortin and Nestin in Hippocampal Regions in App/ps1 Mice

Genes related to neurotransmitter receptors as potential biomarkers for Alzheimer's disease

Identification of Immune Cells and Key Genes associated with Alzheimer's Disease

The Neuro-Inflammatory Microenvironment: an Important Regulator of Stem Cell Survival in Alzheimer’s Disease

Neural Stem Cell Transplants Improve Cognitive Function Without Altering Amyloid Pathology in an App/Ps1 Double Transgenic Model of Alzheimer'S Disease

Preliminary exploration of the co-regulation of Alzheimer's disease pathogenic genes by microRNAs and transcription factors

Identification of key regulatory molecules in the early development stage of Alzheimer's disease

A Transcriptomic Analysis of Nsmce1 Overexpression in Mouse Hippocampal Neuronal Cell by RNA Sequencing

Integrated Identification of Key Genes and Pathways in Alzheimer’s Disease Via Comprehensive Bioinformatical Analyses

Regulation and effects of neurotrophic factors after neural stem cell transplantation in a transgenic mouse model of Alzheimer disease.

Condition-specific Gene Co-Expression Network Mining Identifies Key Pathways and Regulators in the Brain Tissue of Alzheimer's Disease Patients.

Mir-153 Promotes Neural Differentiation by Activating the Cell Adhesion/ca2+ Signaling Pathway and Targeting Ion Channel Activity in HT-22 Cells by Bioinformatic Analysis

Data from single nuclei RNA‐sequencing reveals a prodromal gene network response in excitatory neurons of a humanized rat Alzheimer’s disease model

The characterization of gene expression during mouse neural stem cell differentiation in vitro

Identification of Key Transcriptome Biomarkers Based on a Vital Gene Module Associated with Pathological Changes in Alzheimer's Disease.

Tpr Misregulation in Hippocampal Neural Stem Cells in Mouse Models of Alzheimer's Disease

Comprehensive Analysis Reveals A Six-Gene Signature and Associated Drugs in Alzheimer Disease

P2‐151: MICROARRAY EXPRESSION PROFILE ANALYSIS OF LONG NONCODING RNAS IN TRIPLE TRANSGENIC AD MOUSE BRAIN WITH OR WITHOUT INDUCED T2DM